Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C608351-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,334.90 | |
C608351-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,001.90 |
Synonyms | Pulrodemstat | Pulrodemstat [INN] | W6F4FRQ5QC | 1821307-10-1 | CC-90011 Free base | CC90011 | CC90011 besylate | CC-90011 besylate | 4-(2-(4-Amino-piperidin-1-yl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-4-yl)-2-fluorobenzonitrile | 4-(2-(4-Aminopi |
---|---|
Specifications & Purity | Moligand™ |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of lysine demethylase 1A |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
INCHI | InChI=1S/C24H23F2N5O2/c1-30-23(32)21(14-5-6-20(33-2)19(26)11-14)22(15-3-4-16(13-27)18(25)12-15)29-24(30)31-9-7-17(28)8-10-31/h3-6,11-12,17H,7-10,28H2,1-2H3 |
---|---|
InChi Key | NBAIXBAUHIQQGF-UHFFFAOYSA-N |
Canonical SMILES | N#Cc1ccc(cc1F)c1nc(N2CCC(CC2)N)n(c(=O)c1c1ccc(c(c1)F)OC)C |
Isomeric SMILES | CN1C(=O)C(=C(N=C1N2CCC(CC2)N)C3=CC(=C(C=C3)C#N)F)C4=CC(=C(C=C4)OC)F |
PubChem CID | 118483201 |
Enter Lot Number to search for COA:
1. Fu X, Zhang P, Yu B. (2017) Advances toward LSD1 inhibitors for cancer therapy.. Future Med Chem, 9 (11): (1227-1242). [PMID:28722477] [10.1021/op500134e] |
2. Kanouni T, Severin C, Cho RW, Yuen N Y-Y, Xu J, Shi L, Del Rosario JR, Stansfield RK, Lawton LN, Hosfield D et al.. (2020) Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1). J Med Chem, 71 (13): (1755-70). [PMID:33034194] [10.1021/acs.jmedchem.0c00978] |
3. Fang Y, Liao G, Yu B. (2019) LSD1/KDM1A inhibitors in clinical trials: advances and prospects.. J Hematol Oncol, 12 (1): (129). [PMID:31801559] [10.1021/op500134e] |